NCT03583866View on ClinicalTrials.gov

Adiposity and Endothelin Receptor Function

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 21, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions
Hypertension
Interventions
DRUG

Candesartan

7 days of Candesartan (16mg/day)

DRUG

Placebo

7 days of Placebo

Trial Locations (1)

30912

Georgia Prevention Institute/ Laboratory of Integrative and Exercise Physiology, Augusta

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Augusta University

OTHER